Vectura News

Discover more about our company, science, innovation and people with the latest headlines from Vectura.

Displaying 12 of 66

“Strategies for rapid progression of inhaled products” at Formulation & Delivery Europe Congress: Online

Published15/04/2021

Read more
Will Downie named in The Medicine Maker’s Power List for 2021

Published15/04/2021

Read more
Vectura Group publishes 2020 preliminary results

Published18/03/2021

Read more
Vectura Expands Dry Powder Inhaler Development and Manufacturing Capabilities at its Facility in Chippenham, U.K.

Published05/03/2021

Read more
Vectura Virtual Audits

Published26/02/2021

Read more
Pre-close trading update confirms 2020 trading ahead of expectations

Published12/01/2021

Read more
Vectura Group appoints Jeanne Hecht and Jeanne Thoma to its Board of Directors

Published30/12/2020

Read more
Vectura provides update on GSK litigation

Published29/12/2020

Read more
Vectura earns $11m milestone as Hikma receives US FDA approval for generic Advair Diskus®

Published17/12/2020

Read more
Vectura Expands Capabilities to Handle and Develop Highly Potent Inhaled Drugs at its Facility in Chippenham, U.K.

Published14/12/2020

Read more
Vectura signs agreement with Kinaset Therapeutics Inc. to support the development of VR588 to treat asthma

Published30/11/2020

Read more
Vectura provides update on GSK litigation

Published19/11/2020

Read more

Displaying 12 of 66